Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Endometrial Neoplasms 4Ovarian Neoplasms 2Uterine Cervical Neoplasms 1Genital Neoplasms, Female 1

Interventions

pembrolizumab 3Paclitaxel 3Carboplatin 3niraparib 2anlotinib 2Pemetrexed 2Palliative Care 2Interviews as Topic 2Gemcitabine 2Educational Status 2Bevacizumab 2temsirolimus 1relacorilant 1olaparib 1nilotinib 1liposomal doxorubicin 1lenvatinib 1Watchful Waiting 1Transurethral Resection of Prostate 1Topotecan 1Therapeutic Touch 1Radiotherapy 1Pregnancy Tests 1Ocoxin 1Nivolumab 1Methods 1Laparoscopy 1Human Papillomavirus DNA Tests 1Fulvestrant 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Genital Neoplasms, Female × Diet × Gynecologic × Clear all
NCT00328757 2011-06-28

Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer

Chiang Mai University

Phase 3 Withdrawn
240 enrolled
Gynecologic

Uterine Cervical Neoplasms, Genital Neoplasms, Female, Ovarian Neoplasms, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡